<DOC>
	<DOCNO>NCT02293824</DOCNO>
	<brief_summary>Almost infant bear &lt; 29 week gestational age develop apnea prematurity treat caffeine . Type diet disease state may significant contributor variability caffeine metabolism pharmacokinetics ( PK ) population . This prospective , observational , open-label , opportunistic PK study compare population PK caffeine infant feed formula infant feed exclusively breast milk ; compare activity caffeine metabolize enzyme infant feed formula infant feed exclusively breast milk ; determine effect hypoxia , hypotension , infection caffeine PK metabolism premature infant .</brief_summary>
	<brief_title>Effect Feedings Caffeine Premature Infants</brief_title>
	<detailed_description>This study use consecutive patient sample approach . All eligible participant admit site approach . Caffeine feeding administer per standard care . Manipulations caffeine dose feeding regimen part protocol . To minimize amount blood sampling , investigator use sparse sample methodology . Urine collect analysis caffeine caffeine metabolite concentration . Caffeine pharmacokinetics describe population pharmacokinetic analysis . Urinary concentration caffeine metabolite use calculate metabolic ratio marker enzyme activity .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Caffeine citrate</mesh_term>
	<criteria>Written inform consent parent ( ) legal guardian ( ) &lt; 29 week birth gestational age Postnatal age â‰¤15 day Receiving caffeine ( intravenous oral ) per standard care prevention treatment apnea prematurity Known major congenital chromosomal anomaly</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>15 Days</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Infant , Premature</keyword>
	<keyword>Caffeine</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Metabolism</keyword>
</DOC>